Point-of-care HIV diagnosis for infants: the outcomes we need to achieve

Abstract

Caring for infants and young children living with HIV remains a reality for many families. Despite decades of work leading to a substantial reduction in vertical transmission rates, the stark reality of poor and often late access to HIV diagnosis and subsequent antiretroviral therapy (ART) remains an issue. This is especially true in the African region, where 90% of all HIV-exposed infants reside.1 150 000 children aged 0–9 years acquire HIV globally each year, but less than two-thirds access early infant testing services.